Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S. & EU CARTILAGE REGENERATION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PSETEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 NUMBER OF PROCEDURES PERFORMED PER YEAR: BY COUNTRY
6 REGULATIONS
6.1 EUROPE CARTILAGE REGENERATION MARKET: REGULATIONS
6.1.1 CONFORMITY
6.1.2 CLINICAL INVESTIGATION
6.2 U.S. CARTLAGE REPAIRING MARKET: REGULATIONS
6.2.1 FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH)
6.2.2 FDA CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)
6.2.3 CLINICAL TRIALS OVERSIGHT
6.2.4 POST-MARKET SURVEILLANCE
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF OSTEOARTHRITIS
7.1.2 RISING INVESTMENTS IN RESEARCH AND DEVELOPMENT ACTIVITIES
7.1.3 RISING HEALTHCARE EXPENDITURE TO PROMOTE CARTILAGE REGENERATION TREATMENT
7.1.4 INCREASING NUMBER OF JOINT INJURIES
7.2 RESTRAINTS
7.2.1 POOR REIMBURSEMENT SCENARIO FOR CARTILAGE REGENERATION
7.2.2 STRINGENT REGULATIONS FOR THE APPROVAL OF CARTILAGE REGENERATION PRODUCTS
7.3 OPPORTUNITIES
7.3.1 INCREASE DEMAND FOR MINIMALLY INVASIVE PROCEDURES
7.3.2 RISING TECHNOLOGICAL ADVANCEMENTS IN THE CARTILAGE REGENERATION PROCESS.
7.3.3 RISING AWARENESS OF MEDICAL TREATMENT IN EUROPE
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS IN HEALTHCARE MARKET
7.4.2 HIGH COST OF ORTHOPEDIC IMPLANTS AND SURGERIES
8 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY TYPE
8.1 OVERVIEW
8.2 HYALINE CARTILAGE
8.3 FIBRO CARTILAGE
8.3.1 INTRA-ARTICULAR FIBROCARTILAGE
8.3.2 STRATIFORM FIBROCARTILAGE
8.3.3 CIRCUMFERENTIAL FIBROCARTILAGE
8.3.4 CONNECTING FIBROCARTILAGE
8.4 ELASTIC CARTILAGE
9 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY
9.1 OVERVIEW
9.2 CELL-BASED
9.2.1 CHONDROCYTE TRANSPLANTATION
9.2.1.1 AUTOLOGOUS CHONDROCYTE IMPLANTATION (ACI)
9.2.1.2 MATRIX-INDUCED AUTOLOGOUS CHONDROCYTE IMPLANTATION (MACI)
9.2.2 STEM CELLS
9.2.2.1 MESENCHYMAL STEM CELLS (MSC'S)
9.2.2.2 UMBILICAL CORD-DERIVED STEM CELL THERAPY
9.2.2.3 EMBRYONIC STEM CELL THERAPY
9.2.2.4 OTHERS
9.2.3 GROWTH FACTOR
9.2.3.1 PLATELET-RICH PLASMA (PRP)
9.2.3.2 AUTOLOGOUS CONDITIONED SERUM (ACS)
9.2.3.3 BONE MORPHOGENETIC PROTEIN (BMP) PRODUCTS
9.2.3.4 FIBROBLAST GROWTH FACTOR (FGF) PRODUCTS
9.2.3.5 CONNECTIVE TISSUE GROWTH FACTOR (CTGF) PRODUCTS
9.2.3.6 OTHERS
9.2.4 OTHERS
9.3 NON - CELL BASED
9.3.1 SCAFFOLDS
9.3.1.1 NATURAL
9.3.1.1.1 HYALURONIC ACID (HA) PRODUCTS
9.3.1.1.2 COLLAGEN-BASED SCAFFOLDS
9.3.1.1.3 CHITOSAN SCAFFOLDS
9.3.1.1.4 DECELLULARIZED EXTRACELLULAR MATRIX
9.3.1.1.5 OTHERS
9.3.1.2 SYNTHETIC
9.3.1.2.1 POLY (LACTIC-CO-GLYCOLIC ACID) (PLGA) SCAFFOLDS
9.3.1.2.2 POLYETHYLENE GLYCOL (PEG) HYDROGELS:
9.3.1.2.3 OTHERS
9.3.2 CELL-FREE COMPOSITES
9.3.2.1 ARTIFICIAL CARTILAGE IMPLANT
9.3.2.2 OTHERS
10 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE
10.1 OVERVIEW
10.2 INTRINSIC REPAIR STIMULUS
10.3 PALLIATIVE
10.3.1 DEBRIDEMENT & LAVAGE
10.3.2 VISCOSUPPLEMENTATION
11 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY APPLICATION SITE
11.1 OVERVIEW
11.2 KNEE
11.2.1 OSTEOCHONDRIAL GRAFTS TRANSPLANTATION
11.2.2 AUTOLOGOUS CHONDROCYTE
11.2.3 ARTHROSCOPIC CHONDROPLASTY
11.2.4 MICROFRACTURE
11.2.5 CELL-BASED CARTILAGE RESURFACING
11.2.6 OTHERS
11.3 HIP
11.4 ANKLE
11.5 SPINE
11.6 OTHERS
12 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURES
12.1 OVERVIEW
12.2 OSTEOCHONDRIAL TRANSPLANTATION
12.2.1 OSTEOCHONDRIAL AUTOGRAFT TRANSPLANTATION
12.2.2 OSTEOCHONDRIAL ALLOGRAFT TRANSPLANTATION
12.3 AUTOLOGOUS CHONDROCYTE IMPLANTATION
12.4 MATRIX AUTOLOGOUS CARTILAGE IMPLANTATION (MACI)
12.5 CHONDROPLASTY AND MICROFRACTURE
12.6 OSTEOTOMY
12.7 ARTHROSCOPY
12.8 ABRASION ARTHROPLASTY
12.9 JUVENILE ALLOGRAFT FRAGMENTS
12.1 OTHERS
13 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS AND CLINICS
13.2.1 PRIVATE
13.2.2 PUBLIC
13.3 ACADEMIC AND RESEARCH INSTITUTES
13.4 AMBULATORY SURGICAL CENTERS
13.5 ORTHOCENTERS
13.6 OTHERS
14 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY REGION
14.1 U.S.
14.2 EUROPE
14.2.1 GERMANY
14.2.2 U.K.
14.2.3 FRANCE
14.2.4 ITALY
14.2.5 SPAIN
14.2.6 RUSSIA
14.2.7 POLAND
14.2.8 SWITZERLAND
14.2.9 NETHERLANDS
14.2.10 TURKEY
14.2.11 SWEDEN
14.2.12 BELGIUM
14.2.13 DENMARK
14.2.14 FINLAND
14.2.15 NORWAY
14.2.16 REST OF EUROPE
15 U.S. CARTILAGE REGENERATION MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: U.S.
15.2 COMPANY SHARE ANALYSIS: EUROPE
16 COMPANY PROFILE
16.1 ZIMMER BIOMET
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 VERICEL CORPORATION.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 ARTHREX, INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 PRODUCT PORTFOLIO
16.3.3 RECENT DEVELOPMENT
16.4 CONMED
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 RTI SURGICAL
16.5.1 COMPANY SNAPSHOT
16.5.2 PRODUCT PORTFOLIO
16.5.3 RECENT DEVELOPMENT
16.6 ALLOSOURCE
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ANIKA THERAPEUTICS, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 1.4.4 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 BIOINOVA, A.S.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 CARTILAGE INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 CO.DON
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 GEISTLICH PHARMA AG
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 HISTOGEN INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 LAMINA THERAPEUTICS
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 MEIDRIX BIOMEDICALS GMBH
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 NOVARTIS AG
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 SMITH & NEPHEW
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 TETEC AG
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 U.S. NUMBER OF PROCEDURES PER YEAR
TABLE 2 GERMANY NUMBER OF PROCEDURES PER YEAR
TABLE 3 U.K. NUMBER OF PROCEDURES PER YEAR
TABLE 4 FRANCE NUMBER OF PROCEDURES PER YEAR
TABLE 5 ITALY NUMBER OF PROCEDURES PER YEAR
TABLE 6 SPAIN NUMBER OF PROCEDURES PER YEAR
TABLE 7 RUSSIA NUMBER OF PROCEDURES PER YEAR
TABLE 8 POLAND NUMBER OF PROCEDURES PER YEAR
TABLE 9 SWITZERLAND NUMBER OF PROCEDURES PER YEAR
TABLE 10 NETHERLANDS NUMBER OF PROCEDURES PER YEAR
TABLE 11 TURKEY NUMBER OF PROCEDURES PER YEAR
TABLE 12 SWEDEN NUMBER OF PROCEDURES PER YEAR
TABLE 13 BELGIUM NUMBER OF PROCEDURES PER YEAR
TABLE 14 DENMARK NUMBER OF PROCEDURES PER YEAR
TABLE 15 FINLAND NUMBER OF PROCEDURES PER YEAR
TABLE 16 NORWAY NUMBER OF PROCEDURES PER YEAR
TABLE 17 COST OF PROCEDURES
TABLE 18 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 U.S. & EUROPE FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 20 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 21 U.S. & EUROPE CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 22 U.S. & EUROPE CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 23 U.S. & EUROPE STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 24 U.S. & EUROPE GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 25 U.S. & EUROPE NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 26 U.S. & EUROPE SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 27 U.S. & EUROPE SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 28 U.S. & EUROPE SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 29 U.S. & EUROPE CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 30 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 31 U.S. & EUROPE PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 32 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 33 U.S. & EUROPE KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 34 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 35 U.S. & EUROPE OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 36 U.S. & EUROPE CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 37 U.S. & EUROPE HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 38 U.S. CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 U.S. FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 40 U.S. CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 41 U.S. CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 42 U.S. CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 43 U.S. STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 44 U.S. GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 45 U.S. NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 46 U.S. SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 47 U.S. NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 48 U.S. SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 49 U.S. CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 50 U.S. CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 51 U.S. PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 52 U.S. CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 53 U.S. KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 54 U.S. CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 55 U.S. OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 56 U.S. CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 57 U.S. HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 EUROPE CARTILAGE REGENERATION MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 59 EUROPE CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 EUROPE FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 61 EUROPE CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 62 EUROPE CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 63 EUROPE CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 64 EUROPE STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 65 EUROPE GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 66 EUROPE NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 67 EUROPE SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 68 EUROPE NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 EUROPE SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 EUROPE CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 71 EUROPE CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 EUROPE PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 EUROPE CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 74 EUROPE KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 EUROPE CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 76 EUROPE OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 EUROPE CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 78 EUROPE HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 79 GERMANY CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 GERMANY FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 81 GERMANY CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 82 GERMANY CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 83 GERMANY CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 84 GERMANY STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 85 GERMANY GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 86 GERMANY NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 87 GERMANY SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 88 GERMANY NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 89 GERMANY SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 90 GERMANY CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 91 GERMANY CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 92 GERMANY PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 GERMANY CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 94 GERMANY KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 GERMANY CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 96 GERMANY OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 GERMANY CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 98 GERMANY HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 U.K. CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 100 U.K. FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 101 U.K. CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 102 U.K. CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 103 U.K. CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 104 U.K. STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 105 U.K. GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 106 U.K. NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 107 U.K. SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 108 U.K. NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 U.K. SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 U.K. CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 111 U.K. CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 112 U.K. PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 113 U.K. CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 114 U.K. KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 115 U.K. CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 116 U.K. OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 U.K. CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 118 U.K. HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 FRANCE CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 FRANCE FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 FRANCE CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 122 FRANCE CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 123 FRANCE CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 124 FRANCE STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 125 FRANCE GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 126 FRANCE NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 127 FRANCE SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 128 FRANCE NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 FRANCE SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 FRANCE CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 131 FRANCE CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 FRANCE PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 133 FRANCE CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 134 FRANCE KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 FRANCE CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 136 FRANCE OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 FRANCE CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 138 FRANCE HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 139 ITALY CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 ITALY FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 ITALY CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 142 ITALY CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 143 ITALY CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 144 ITALY STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 145 ITALY GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 146 ITALY NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 147 ITALY SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 148 ITALY NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 ITALY SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 150 ITALY CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 151 ITALY CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 152 ITALY PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 153 ITALY CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 154 ITALY KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 ITALY CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 156 ITALY OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 ITALY CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 158 ITALY HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 SPAIN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 160 SPAIN FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 161 SPAIN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 162 SPAIN CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 163 SPAIN CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 164 SPAIN STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 165 SPAIN GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 166 SPAIN NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 167 SPAIN SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 168 SPAIN NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 SPAIN SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 170 SPAIN CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 171 SPAIN CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 172 SPAIN PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 173 SPAIN CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 174 SPAIN KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 175 SPAIN CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 176 SPAIN OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 SPAIN CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 178 SPAIN HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 RUSSIA CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 RUSSIA FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 RUSSIA CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 182 RUSSIA CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 183 RUSSIA CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 184 RUSSIA STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 185 RUSSIA GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 186 RUSSIA NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 187 RUSSIA SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 188 RUSSIA NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 189 RUSSIA SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 190 RUSSIA CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 191 RUSSIA CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 192 RUSSIA PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 193 RUSSIA CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 194 RUSSIA KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 RUSSIA CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 196 RUSSIA OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 197 RUSSIA CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 198 RUSSIA HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 POLAND CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 200 POLAND FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 201 POLAND CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 202 POLAND CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 203 POLAND CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 204 POLAND STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 205 POLAND GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 206 POLAND NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 207 POLAND SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 208 POLAND NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 209 POLAND SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 210 POLAND CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 211 POLAND CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 212 POLAND PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 213 POLAND CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 214 POLAND KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 215 POLAND CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 216 POLAND OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 POLAND CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 218 POLAND HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 219 SWITZERLAND CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 220 SWITZERLAND FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 221 SWITZERLAND CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 222 SWITZERLAND CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 223 SWITZERLAND CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 224 SWITZERLAND STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 225 SWITZERLAND GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 226 SWITZERLAND NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 227 SWITZERLAND SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 228 SWITZERLAND NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 229 SWITZERLAND SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 230 SWITZERLAND CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 231 SWITZERLAND CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 232 SWITZERLAND PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 233 SWITZERLAND CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 234 SWITZERLAND KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 235 SWITZERLAND CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 236 SWITZERLAND OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 237 SWITZERLAND CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 238 SWITZERLAND HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 239 NETHERLANDS CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 240 NETHERLANDS FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 241 NETHERLANDS CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 242 NETHERLANDS CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 243 NETHERLANDS CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 244 NETHERLANDS STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 245 NETHERLANDS GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 246 NETHERLANDS NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 247 NETHERLANDS SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 248 NETHERLANDS NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 249 NETHERLANDS SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 250 NETHERLANDS CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 251 NETHERLANDS CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 252 NETHERLANDS PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 253 NETHERLANDS CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 254 NETHERLANDS KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 255 NETHERLANDS CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 256 NETHERLANDS OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 257 NETHERLANDS CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 258 NETHERLANDS HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 259 TURKEY CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 260 TURKEY FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 261 TURKEY CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 262 TURKEY CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 263 TURKEY CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 264 TURKEY STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 265 TURKEY GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 266 TURKEY NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 267 TURKEY SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 268 TURKEY NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 269 TURKEY SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 270 TURKEY CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 271 TURKEY CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 272 TURKEY PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 273 TURKEY CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 274 TURKEY KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 275 TURKEY CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 276 TURKEY OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 277 TURKEY CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 278 TURKEY HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 279 SWEDEN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 280 SWEDEN FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 281 SWEDEN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 282 SWEDEN CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 283 SWEDEN CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 284 SWEDEN STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 285 SWEDEN GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 286 SWEDEN NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 287 SWEDEN SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 288 SWEDEN NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 289 SWEDEN SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 290 SWEDEN CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 291 SWEDEN CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 292 SWEDEN PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 293 SWEDEN CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 294 SWEDEN KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 295 SWEDEN CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 296 SWEDEN OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 297 SWEDEN CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 298 SWEDEN HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 299 BELGIUM CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 300 BELGIUM FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 301 BELGIUM CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 302 BELGIUM CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 303 BELGIUM CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 304 BELGIUM STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 305 BELGIUM GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 306 BELGIUM NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 307 BELGIUM SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 308 BELGIUM NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 309 BELGIUM SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 310 BELGIUM CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 311 BELGIUM CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 312 BELGIUM PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 313 BELGIUM CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 314 BELGIUM KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 315 BELGIUM CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 316 BELGIUM OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 317 BELGIUM CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 318 BELGIUM HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 319 DENMARK CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 320 DENMARK FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 321 DENMARK CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 322 DENMARK CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 323 DENMARK CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 324 DENMARK STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 325 DENMARK GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 326 DENMARK NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 327 DENMARK SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 328 DENMARK NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 329 DENMARK SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 330 DENMARK CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 331 DENMARK CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 332 DENMARK PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 333 DENMARK CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 334 DENMARK KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 335 DENMARK CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 336 DENMARK OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 337 DENMARK CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 338 DENMARK HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 339 FINLAND CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 340 FINLAND FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 341 FINLAND CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 342 FINLAND CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 343 FINLAND CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 344 FINLAND STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 345 FINLAND GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 346 FINLAND NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 347 FINLAND SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 348 FINLAND NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 349 FINLAND SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 350 FINLAND CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 351 FINLAND CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 352 FINLAND PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 353 FINLAND CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 354 FINLAND KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 355 FINLAND CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 356 FINLAND OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 357 FINLAND CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 358 FINLAND HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 359 NORWAY CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 360 NORWAY FIBRO CARTILAGE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 361 NORWAY CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 362 NORWAY CELL-BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 363 NORWAY CHRONDOCYTE TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 364 NORWAY STEM CELLS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 365 NORWAY GROWTH FACTOR IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 366 NORWAY NON-CELL BASED IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 367 NORWAY SCAFFOLDS IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 368 NORWAY NATURAL IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 369 NORWAY SYNTHETIC IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 370 NORWAY CELL-FREE COMPOSITES IN CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2022-2031 (USD THOUSAND)
TABLE 371 NORWAY CARTILAGE REGENERATION MARKET, BY TREATMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 372 NORWAY PALLIATIVE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 373 NORWAY CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2022-2031 (USD THOUSAND)
TABLE 374 NORWAY KNEE IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 375 NORWAY CARTILAGE REGENERATION MARKET, BY SURGICAL PROCEDURE, 2022-2031 (USD THOUSAND)
TABLE 376 NORWAY OSTEOCHONDRIAL TRANSPLANTATION IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 377 NORWAY CARTILAGE REGENERATION MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 378 NORWAY HOSPITALS AND CLINICS IN CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 379 REST OF EUROPE CARTILAGE REGENERATION MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
List of Figure
FIGURE 1 U.S. & EU CARTILAGE REGENERATION MARKET: SEGMENTATION
FIGURE 2 U.S. & EU CARTILAGE REGENERATION MARKET: DATA TRIANGULATION
FIGURE 3 U.S. & EU CARTILAGE REGENERATION MARKET: DROC ANALYSIS
FIGURE 4 U.S. & EU CARTILAGE REGENERATION MARKET: REGIONAL VS COUNTRYMARKET ANALYSIS
FIGURE 5 U.S. & EU CARTILAGE REGENERATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. & EU CARTILAGE REGENERATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. & EU CARTILAGE REGENERATION MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 U.S. & EU CARTILAGE REGENERATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 U.S. & EU CARTILAGE REGENERATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 U.S. & EU CARTILAGE REGENERATION MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF OSTEOARTHRITIS AND RISING HEALTHCARE EXPENDITURE ARE DRIVING THE GROWTH OF THE U.S. & EU CARTILAGE REGENERATION MARKET FROM 2024 TO 2034
FIGURE 12 HYALINE CARTILAGE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. AND EU CARTILAGE REGENERATION MARKET IN 2024 TO 2031
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE U.S. & EU CARTILAGE REGENERATION MARKET
FIGURE 14 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY TYPE, 2023
FIGURE 15 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 16 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY TYPE, CAGR (2024-2031)
FIGURE 17 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY TYPE, LIFELINE CURVE
FIGURE 18 U.S. & EUROPE CARTILAGE REGENERATION MARKET: BY TREATMENT MODALITY, 2022
FIGURE 19 U.S. & EUROPE CARTILAGE REGENERATION MARKET: BY TREATMENT MODALITY, 2024-2031 (USD THOUSAND)
FIGURE 20 U.S. & EUROPE CARTILAGE REGENERATION MARKET: BY TREATMENT MODALITY, CAGR (2024-2031)
FIGURE 21 U.S. & EUROPE CARTILAGE REGENERATION MARKET: BY TREATMENT MODALITY, LIFELINE CURVE
FIGURE 22 U.S. & EUROPE CARTILAGE REGENERATION MARKET: BY TREATMENT TYPE, 2022
FIGURE 23 U.S. & EUROPE CARTILAGE REGENERATION MARKET: BY TREATMENT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 24 U.S. & EUROPE CARTILAGE REGENERATION MARKET: BY TREATMENT TYPE, CAGR (2024-2031)
FIGURE 25 U.S. & EUROPE CARTILAGE REGENERATION MARKET: BY TREATMENT TYPE, LIFELINE CURVE
FIGURE 26 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY APPLICATION SITE, 2023
FIGURE 27 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY APPLICATION SITE, 2024-2031 (USD THOUSAND)
FIGURE 28 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY APPLICATION SITE, CAGR (2024-2031)
FIGURE 29 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY APPLICATION SITE, LIFELINE CURVE
FIGURE 30 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY SURGICAL PROCEDURE , 2023
FIGURE 31 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY SURGICAL PROCEDURE , 2024-2031 (USD THOUSAND)
FIGURE 32 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY SURGICAL PROCEDURE, CAGR (2024-2031)
FIGURE 33 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY SURGICAL PROCEDURE, LIFELINE CURVE
FIGURE 34 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY END USER, 2023
FIGURE 35 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 36 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY END USER, CAGR (2024-2031)
FIGURE 37 U.S. & EUROPE CARTILAGE REGENERATION MARKET : BY END USER, LIFELINE CURVE
FIGURE 38 EUROPE CARTILAGE REGENERATION MARKET: SNAPSHOT (2023)
FIGURE 39 U.S. CARTILAGE REGENERATION MARKET: COMPANY SHARE 2023 (%)
FIGURE 40 EUROPE CARTILAGE REGENERATION MARKET: COMPANY SHARE 2023 (%)
